The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study
- PMID: 33957874
- PMCID: PMC8101120
- DOI: 10.1186/s12876-021-01745-1
The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study
Abstract
Background: The projection studies are imperative to satisfy demands for health care systems and proper response to the public health problems such as inflammatory bowel disease (IBD).
Methods: To accomplish this, we established an illness-death model based on available data to project the future prevalence of IBD in Asia, Iran in particular, separately from 2017 to 2035. We applied two deterministic and stochastic approaches.
Results: In 2035, as compared to 2020, we expected a 2.5-fold rise in prevalence for Iran with 69 thousand cases, a 2.3-fold increment for North Africa and the Middle East with 220 thousand cases, quadrupling of the prevalence for India with 2.2 million cases, a 1.5-fold increase for East Asia region with 4.5 million cases, and a 1.6-fold elevation in prevalence for high-income Asia-Pacific and Southeast Asia regions with 183 and 199 thousand cases respectively.
Conclusions: Our results showed an emerging epidemic for the prevalence of IBD in Asia regions and/or countries. Hence, we suggest the need for immediate action to control this increasing trend in Asia and Iran. However, we were virtually unable to use information about age groups, gender, and other factors influencing the evolution of IBD in our model due to lack of access to reliable data.
Keywords: Asia regions; Emergency action; Inflammatory Bowel Disease; Iran; Projection.
Conflict of interest statement
The authors have no conflicts of interest to declare for this study.
Figures





Similar articles
-
Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific.Am J Gastroenterol. 2019 Jan;114(1):107-115. doi: 10.1038/s41395-018-0233-2. Am J Gastroenterol. 2019. PMID: 30177785
-
Epidemiology of inflammatory bowel disease in Asia.Indian J Gastroenterol. 2007 Nov-Dec;26(6):285-9. Indian J Gastroenterol. 2007. PMID: 18431013 Review.
-
Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences.J Dig Dis. 2010 Jun;11(3):134-47. doi: 10.1111/j.1751-2980.2010.00429.x. J Dig Dis. 2010. PMID: 20579217 Review.
-
An update on the epidemiology of inflammatory bowel disease in Asia.Am J Gastroenterol. 2008 Dec;103(12):3167-82. doi: 10.1111/j.1572-0241.2008.02158.x. Am J Gastroenterol. 2008. PMID: 19086963 Review.
-
Management consensus of inflammatory bowel disease for the Asia-Pacific region.J Gastroenterol Hepatol. 2006 Dec;21(12):1772-82. doi: 10.1111/j.1440-1746.2006.04674.x. J Gastroenterol Hepatol. 2006. PMID: 17074013 Review.
Cited by
-
Obesity, a challenge in the management of inflammatory bowel diseases.Immunol Res. 2022 Dec;70(6):742-751. doi: 10.1007/s12026-022-09315-7. Epub 2022 Aug 29. Immunol Res. 2022. PMID: 36031674 Review.
-
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries.United European Gastroenterol J. 2022 Dec;10(10):1063-1076. doi: 10.1002/ueg2.12350. Epub 2022 Dec 8. United European Gastroenterol J. 2022. PMID: 36479863 Free PMC article. Review.
-
Non-alcoholic fatty liver disease (NAFLD) and obesity in inflammatory bowel disease (IBD) patients in Gorgan.Caspian J Intern Med. 2024 Spring;15(2):299-306. doi: 10.22088/cjim.15.2.299. Caspian J Intern Med. 2024. PMID: 38807729 Free PMC article.
-
A systematic review and meta-analysis of extra-intestinal manifestation of inflammatory bowel disease in the Eastern Mediterranean Region (EMRO) countries.Ann Med Surg (Lond). 2024 Apr 15;86(5):2892-2899. doi: 10.1097/MS9.0000000000001543. eCollection 2024 May. Ann Med Surg (Lond). 2024. PMID: 38694357 Free PMC article. Review.
-
Toll-Like Receptor 7 a Novel Non-Invasive Inflammatory Genetic Sensor for Ulcerative Colitis Remission Monitoring.Adv Biomed Res. 2023 Feb 25;12:54. doi: 10.4103/abr.abr_24_22. eCollection 2023. Adv Biomed Res. 2023. PMID: 37057238 Free PMC article.
References
-
- Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet (London, England) 2018;390(10114):2769–2778. doi: 10.1016/S0140-6736(17)32448-0. - DOI - PubMed
-
- Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142(1):46–54.e42; quiz e30. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources